ArticleBiophysical journal2026
Biophysical insights into a cryptic ligand site in the hydrophobic core of human PCNA.
Article in Biophysical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Proteins contain small pockets that form due to imperfections in residue packing or the rotational and conformational movement of amino acids. In this work, we used the fluorescent probe 1-aminoanthracene (AMA) to detect a small ligand pocket in the hydrophobic core of human proliferating cell nuclear antigen (PCNA), which is a critical protein for DNA replication and repair. Fluorescence measurements of AMA reported that the core of PCNA had a dielectric constant (ε) of 4, which was very apolar and similar to cyclohexane (ε = 2). Protein mutagenesis, photoaffinity labeling, and molecular dynamics simulations localized the binding site for AMA next to PCNA residues L90 and L101, which also interacted with general anesthetics (sevoflurane and propofol). The ligand binding site was cryptic, i.e., it formed transiently and was only detectable in certain structural states of PCNA. Ligand binding to the cryptic site on PCNA structurally stabilized the trimeric protein and reduced its ability to disassemble and reassemble its subunits. Thus, the cryptic site in PCNA's core serves to destabilize the assembled protein and promotes structural and oligomeric flexibility. Finally, the hydrophobic site is widely conserved among homologous β clamp proteins with a similar fold as PCNA. This work highlights how small fluorescent probes can reveal ligand sites within proteins, defines the chemical features of protein hydrophobic cores, and introduces a novel approach to modulate the oligomeric stability of PCNA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.